Louis C. Lucido - 28 Jun 2024 Form 4 Insider Report for BioCorRx Inc. (BICX)

Role: President, Director, 10%+ Owner
Signature: /s/ Louis C. Lucido
Issuer symbol: BICX
Transactions as of: 28 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 10 Jul 2024, 13:02:37 UTC
Previous filing: 03 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BICX	Common Stock, par value $0.001	Award	$0	+10,204	+1.8%	$0.000000	588,800	28 Jun 2024	Direct	F1
transaction	BICX	Common Stock, par value $0.001	Award	$0	+34,016	+5.8%	$0.000000	622,816	28 Jun 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the "Company") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the "Common Stock") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49.
F2	These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the "Agreement"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49.

Content

These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. (the "Company") and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock par value $0.001 per share (the "Common Stock") equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49.

These shares were issued to Mr. Lucido pursuant to an Executive Service Agreement (the "Agreement"), dated January 5, 2024, by and between Company and Mr. Lucido. As compensation for his services under the Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.49.